Showing 1 - 3 results of 3 for search 'Dongsheng Tu', query time: 0.01s Refine Results
  1. 1
    Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial

    Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analy... by Chang Yin, Josee-Lyne Ethier, Mark S. Carey, Dongsheng Tu, Xueying Zheng

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy

    Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy by Aijun Zhao, Dongsheng Tu, Ye He, Liu Liu, Bin Wu, Yixing Ren

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial

    Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial by Christopher O’Callaghan, Scott Berry, Petr Kavan, Jonathan M Loree, Felix Couture, Dongsheng Tu, Sheryl Koski, Lucy X Ma, Emma Titmuss, Derek J Jonker, Hagen F Kennecke, Chaudhary E Ahmad, John R Goffin, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Eric X Chen

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: